Document is current
Any future updates will be listed below
-
Authors
Ahdritz, Gustaf https://orcid.org/0000-0001-8283-5324
Bouatta, Nazim https://orcid.org/0000-0002-6524-874X
Floristean, Christina
Kadyan, Sachin
Xia, Qinghui
Gerecke, William
O’Donnell, Timothy J.
Berenberg, Daniel
Fisk, Ian
Zanichelli, Niccolò
Zhang, Bo https://orcid.org/0000-0002-9714-2827
Nowaczynski, Arkadiusz
Wang, Bei
Stepniewska-Dziubinska, Marta M.
Zhang, Shang
Ojewole, Adegoke https://orcid.org/0000-0003-2661-4388
Guney, Murat Efe
Biderman, Stella
Watkins, Andrew M.
Ra, Stephen
Lorenzo, Pablo Ribalta
Nivon, Lucas
Weitzner, Brian https://orcid.org/0000-0002-1909-0961
Ban, Yih-En Andrew
Chen, Shiyang https://orcid.org/0000-0003-2626-7865
Zhang, Minjia
Li, Conglong
Song, Shuaiwen Leon
He, Yuxiong
Sorger, Peter K. https://orcid.org/0000-0002-3364-1838
Mostaque, Emad
Zhang, Zhao https://orcid.org/0000-0001-5921-0035
Bonneau, Richard
AlQuraishi, Mohammed https://orcid.org/0000-0001-6817-1322
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM150546)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM150546)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM150546)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54-CA225088)
National Science Foundation (OAC-2106661)
National Science Foundation (OAC-2112606)
- License Information
-
More Information
Article History
Received: 14 August 2023
Accepted: 3 April 2024
First Online: 14 May 2024
Competing interests
: M.A. is a member of the scientific advisory boards of Cyrus Biotechnology, Deep Forest Sciences, Nabla Bio, Oracle Therapeutics and FL2021-002, a Foresite Labs company. P.K.S. is a cofounder and member of the BOD of Glencoe Software, member of the BOD for Applied BioMath and a member of the SAB for RareCyte, NanoString, Reverb Therapeutics and Montai Health; he holds equity in Glencoe, Applied BioMath and RareCyte. L.N. is an employee of Cyrus Biotechnology. The other authors declare no competing interests.
